Skip to main content
Clinical Trials/EUCTR2015-000829-37-NL
EUCTR2015-000829-37-NL
Active, not recruiting
Phase 1

Fluid hydration to prevent post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis: the FLUYT-prevent trial. a multicenter randomized controlled superiority trial. - FLUYT-prevent trial

Radboud University Medical Center0 sites826 target enrollmentApril 21, 2015

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Patients with choledocholithiasis
Sponsor
Radboud University Medical Center
Enrollment
826
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 21, 2015
End Date
TBD
Last Updated
last year
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age between 17 and 86
  • written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 750
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 76

Exclusion Criteria

  • 1\) Allergy to NSAID’s or other contraindications
  • 2\) Ongoing acute pancreatitis
  • 3\) Ongoing hypotension, including those with sepsis
  • 4\) Cardiac insufficiency (CI, \>NYHA Class II heart failure)
  • 5\) Renal insufficiency (RI, creatinin clearance \<40ml/min)
  • 6\) Active ulcer disease
  • 7\) Severe liver dysfunction: Liver cirrhosis and ascites
  • 8\) Respiratory insufficiency (pO2\<60mmHg or 90% despite FiO2 of 30% or requiring mechanical ventilation).
  • 9\) Pregnancy
  • 10\) Hyponatremia (Na\+ levels \< 130mmol/l)

Outcomes

Primary Outcomes

Not specified

Similar Trials